Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

1338 - Investigation of the clinicopathological features of vulva cancer: a retrospective survey of the JGOG Net Work study.


09 Sep 2017


Poster display session


Vulvar and Vaginal Cancers


Shin Nishio


Annals of Oncology (2017) 28 (suppl_5): v330-v354. 10.1093/annonc/mdx372


S. Nishio1, T. Shibata2, S. Yamaguchi3, H. Kanao4, A. Kojima5, M. Takekuma6, A. Tozawa7, H. Tokunaga8, E. Miyagi9, H. Kato10, K. Kurihara11, T. Yanase12, K. Ushijima1, M. Mikami13, T. Sugiyama14

Author affiliations

  • 1 Obstetrics And Gynecology, Kurume University, 830-0011 - Kurume/JP
  • 2 Molecular Life Sciences, Tokai University, Isehara/JP
  • 3 Gynecology, Hyogo Cancer Center, Akashi/JP
  • 4 Gynecology, Cancer Institute Hospital, Tokyo/JP
  • 5 Obstetrics And Gynecology, Iwate Medical University, Morioka/JP
  • 6 Gynecologic Oncology, Shizuoka Cancer Center, Shizuoka/JP
  • 7 Obstetrics And Gynecology, St. Marianna University, Kawasaki/JP
  • 8 Obstetrics And Gynecology, Tohoku University Hospital, Sendai/JP
  • 9 Obstetrics And Gynecology, Yokohama City University Hospital, Yokohama/JP
  • 10 Gynecology, Kanagawa Cancer Center, Yokohama/JP
  • 11 Gynecology, Saitama Cancer Center, Saitama/JP
  • 12 Gynecology, Niigata Cancer Center Hospital, Niigata/JP
  • 13 Obstetrics And Gynecology, Tokai Univeresity Hospital, Isehara/JP
  • 14 Department Of Obstetrics And Gynecology, Iwate Medical University School of Medicine, 020-8505 - Morioka/JP


Abstract 1338


Vulvar cancer is a rare malignancy in women. During the past 30 years, large surveys of vulva cancer have not been performed in Japan. We therefore conducted a multicenter study to clarify the clinicopathological features of vulva cancer in Japan (UMIN000017080).


In this multicenter retrospective cohort study, the clinical data of patients with vulva cancer were surveyed. The medical records of patients with vulvar cancer patients treated between 2001 and 2010 were retrospectively reviewed after obtaining approval from the Institutional Review Board of each institution. Survival analysis was performed using Kaplan-Meier curves. The effects of the clinical factors on OS were investigated using a Cox regression model.


A total of 1082 patients treated in 108 centers were studied. The median age was 72 years (range, 20 to 96). The disease stage was stage I in 415 patients (38.3%), stage II in 249 (23%), stage III in 255 (23.6%), and stage IV in 163 (15.1%) (FIGO 2009). The diagnosis was squamous cell carcinoma in 779 patients (72%), Paget’s disease in 158 (14.6%), adenocarcinoma in 63 (5.8%), and others in 82 (7.6%). Positive lymph nodes were found in 237 patients (21.9%). The median tumor diameter was 35 mm (range, 1 to 180). The 5-year overall survival was 86% in stage I, 74.7% in stage II, 48.2% in stage III, and 39.3% in stage IV (P 


Treatment outcomes in Japanese patients with vulvar cancer were similar to those reported previously. However, squamous-cell carcinoma, adenocarcinoma, positive lymph nodes, and bulky tumors were associated with poor outcomes. Multidisciplinary treatment might be required in patients with these characteristics.

Clinical trial identification

Registry Name: UMIN Clinical Trials Registry Registration Number: UMIN000017080

Legal entity responsible for the study





All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.